data_1ag7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ag7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.74 ' HG ' ' HG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.74 ' HG ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' OE1' ' SG ' ' A' ' 19' ' ' CYS . 1.5 mt-30 -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' H ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.834 0.35 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.439 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.874 0.368 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.074 0.464 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.675 ' HG ' ' HG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.675 ' HG ' ' HG ' ' A' ' 3' ' ' SER . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.463 ' H ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.252 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.506 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.504 2.238 0 CA-C-O 119.473 -0.298 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 . . . . . 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.635 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.579 ' HG ' HH11 ' A' ' 8' ' ' ARG . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.579 HH11 ' HG ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.454 HH21 ' CD1' ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CD1' HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 p -53.86 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 124.907 1.379 . . . . 0.0 113.988 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.74 ' HG ' ' HG ' ' A' ' 7' ' ' SER . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.74 ' HG ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p -123.87 147.03 47.99 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.579 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.579 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -48.95 129.88 17.75 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 32' ' ' CGU . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -88.13 28.95 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.416 ' H ' ' C ' ' A' ' 30' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.03 36.36 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.104 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.352 -1.785 . . . . 0.0 109.14 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p -56.3 178.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 125.053 1.471 . . . . 0.0 113.133 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.6 p -114.55 138.73 50.27 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.58 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.58 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -51.35 135.22 27.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' OE1' ' SG ' ' A' ' 19' ' ' CYS . 1.5 mt-30 -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 32.19 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.92 48.02 0.86 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.076 -1.875 . . . . 0.0 108.052 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.5 -1.714 . . . . 0.0 109.234 -179.885 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p -54.85 178.56 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 113.655 -1.611 . . . . 0.0 114.857 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.96 150.1 45.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.6 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.6 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.477 HE21 ' HD1' ' A' ' 10' ' ' HYP . 90.9 mm-40 -44.57 130.5 6.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.609 1.193 . . . . 0.0 109.16 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.02 59.09 3.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -158.28 52.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 116.396 -1.764 . . . . 0.0 108.584 179.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p -119.83 175.26 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.681 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' H ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p -121.96 150.08 42.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.528 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.528 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.9 129.66 2.08 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.149 0.906 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -116.49 67.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.461 ' CD1' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.461 ' H ' ' CD1' ' A' ' 32' ' ' CGU . 3.3 t70 -162.47 34.66 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.109 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -67.57 -175.75 0.55 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.407 HH11 ' CD2' ' A' ' 32' ' ' CGU . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -128.49 145.48 51.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.55 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.55 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -42.36 129.3 3.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.712 1.258 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.439 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -98.45 33.39 2.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.407 ' CD2' HH11 ' A' ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.9 50.74 0.9 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 111.347 -2.661 . . . . 0.0 107.327 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 117.244 -1.36 . . . . 0.0 111.679 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p -124.7 176.95 6.24 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.835 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p -114.93 151.3 34.29 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.485 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.485 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -39.99 124.64 1.83 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.426 1.079 . . . . 0.0 109.974 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -92.84 59.37 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.37 49.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.781 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.303 -1.332 . . . . 0.0 110.83 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.71 -178.65 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 125.01 1.444 . . . . 0.0 113.637 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.48 128.11 5.12 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.595 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.595 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -46.01 129.26 9.69 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.577 1.173 . . . . 0.0 108.609 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -92.9 31.37 1.41 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -100.15 50.93 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 112.167 -2.288 . . . . 0.0 108.293 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p -58.37 179.89 0.07 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 124.899 1.374 . . . . 0.0 112.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -134.45 152.99 52.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.608 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.608 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.537 HE21 ' HD1' ' A' ' 10' ' ' HYP . 87.0 mm-40 -46.12 129.77 10.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.566 1.166 . . . . 0.0 108.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -86.75 51.4 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.6 37.23 1.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.597 -1.668 . . . . 0.0 108.858 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -121.96 176.39 5.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.274 0.984 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.53 144.96 41.13 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.507 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.507 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -39.69 123.97 1.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.196 0.935 . . . . 0.0 110.124 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.14 39.98 1.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.65 30.92 2.83 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.33 -1.795 . . . . 0.0 109.124 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p -114.74 178.8 4.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 123.914 0.759 . . . . 0.0 110.506 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -117.69 147.49 42.88 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.564 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.564 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -47.49 128.03 11.9 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -93.15 35.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.427 ' C ' ' H ' ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.58 41.91 1.08 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.809 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.427 ' H ' ' C ' ' A' ' 32' ' ' CGU . 10.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.991 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p -52.58 174.07 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.624 1.203 . . . . 0.0 113.223 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p -114.34 144.5 43.17 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.564 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.564 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.1 130.55 6.07 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.297 0.998 . . . . 0.0 109.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -95.54 38.57 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.4 42.07 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 115.703 -2.094 . . . . 0.0 109.967 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 p -45.42 169.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.77 1.294 . . . . 0.0 114.442 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p -121.7 148.59 44.4 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.521 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.521 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -41.48 124.06 2.32 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.188 0.93 . . . . 0.0 109.34 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.79 38.59 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 53.33 36.03 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.936 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 116.397 -1.763 . . . . 0.0 108.509 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p -103.36 179.25 4.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.12 0.888 . . . . 0.0 110.845 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -148.58 124.72 10.77 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.569 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.569 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -47.39 119.81 2.88 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -87.32 47.36 1.49 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -122.82 56.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.055 -1.43 . . . . 0.0 107.282 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.991 -179.841 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p -126.37 171.76 10.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.64 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.675 ' HG ' ' HG ' ' A' ' 7' ' ' SER . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.439 HH21 ' CD1' ' A' ' 32' ' ' CGU . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.675 ' HG ' ' HG ' ' A' ' 3' ' ' SER . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.463 ' H ' ' CD ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p -116.83 148.04 41.6 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.484 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.484 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -39.91 122.64 1.49 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.246 0.966 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.506 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.506 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -92.14 40.69 1.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.439 ' CD1' HH21 ' A' ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 t70 52.76 35.44 18.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.101 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.556 -1.688 . . . . 0.0 108.137 -179.918 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.21 171.94 12.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.826 0.704 . . . . 0.0 112.678 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p -110.96 149.16 31.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.525 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.525 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -39.97 126.5 2.06 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.459 1.099 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -88.67 43.75 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.403 ' C ' ' H ' ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.56 34.89 0.88 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.342 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 32' ' ' CGU . 9.0 p . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 116.017 -1.944 . . . . 0.0 109.832 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p -114.92 179.08 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.507 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.99 130.86 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.559 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.559 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -40.08 127.68 2.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.581 1.176 . . . . 0.0 110.414 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -95.78 45.02 1.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.26 43.93 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.638 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.387 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.903 0.382 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p -127.18 175.6 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.635 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -111.93 149.66 31.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.511 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.511 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -39.77 126.22 1.93 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.968 1.417 . . . . 0.0 110.622 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -89.26 44.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.45 32.54 3.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.085 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.498 1.941 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.262 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 p -52.8 175.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p -137.28 143.84 42.38 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.584 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.584 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.84 130.7 25.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -93.96 42.98 1.1 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -141.54 34.58 1.64 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.527 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 116.022 -1.942 . . . . 0.0 108.415 -179.822 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p -117.25 177.92 4.55 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.804 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.579 ' HG ' HH11 ' A' ' 8' ' ' ARG . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.579 HH11 ' HG ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.11 130.51 5.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.585 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.585 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -40.03 127.25 2.16 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.723 1.264 . . . . 0.0 110.758 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -95.69 52.8 1.38 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.427 ' CG ' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 32' ' ' CGU . 2.4 t70 -155.71 56.02 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.552 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 116.783 -1.579 . . . . 0.0 109.525 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p -60.21 -178.75 0.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.805 1.316 . . . . 0.0 111.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.86 145.41 44.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HYP . . . . . 0.575 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HYP . . . . . 0.575 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -50.15 132.45 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.454 HH21 ' CD1' ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.454 ' CD1' HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -95.84 50.28 1.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CGU . . . . . 0.47 ' CG ' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.47 ' H ' ' CG ' ' A' ' 32' ' ' CGU . 0.1 OUTLIER -126.89 32.99 5.01 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.671 -2.059 . . . . 0.0 106.081 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.384 -1.769 . . . . 0.0 111.319 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.563 ' SG ' ' NE2' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' NE2' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.44 ' CB ' HD21 ' A' ' 17' ' ' LEU . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' SER . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' GLY . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.834 0.35 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' CB ' HD21 ' A' ' 17' ' ' LEU . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' HH21 ' A' ' 18' ' ' ARG . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.407 ' CB ' HD21 ' A' ' 17' ' ' LEU . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 25' ' ' GLN . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 22' ' ' GLY . 13.5 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.874 0.368 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.413 ' CB ' HD21 ' A' ' 17' ' ' LEU . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' HG3' HD21 ' A' ' 17' ' ' LEU . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' NE ' HD11 ' A' ' 28' ' ' ILE . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 17' ' ' LEU . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.074 0.464 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.252 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' HD11 ' A' ' 28' ' ' ILE . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' NE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.543 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.504 2.238 0 CA-C-O 119.473 -0.298 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 . . . . . 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.691 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 22' ' ' GLY . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.467 HD11 ' HE ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.573 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 25' ' ' GLN . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 30.3 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 6.5 p -53.86 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 124.907 1.379 . . . . 0.0 113.988 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p -123.87 147.03 47.99 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.675 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.675 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -48.95 129.88 17.75 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -88.13 28.95 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.03 36.36 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.104 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.352 -1.785 . . . . 0.0 109.14 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p -56.3 178.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 125.053 1.471 . . . . 0.0 113.133 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 10' ' ' HYP . 22.6 p -114.55 138.73 50.27 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.667 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.667 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -51.35 135.22 27.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.563 ' SG ' ' NE2' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' NE2' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 32.19 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.92 48.02 0.86 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.076 -1.875 . . . . 0.0 108.052 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.5 -1.714 . . . . 0.0 109.234 -179.885 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p -54.85 178.56 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 113.655 -1.611 . . . . 0.0 114.857 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.96 150.1 45.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.691 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.691 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -44.57 130.5 6.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.609 1.193 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.02 59.09 3.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -158.28 52.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 116.396 -1.764 . . . . 0.0 108.584 179.827 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p -119.83 175.26 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.681 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.44 ' CB ' HD21 ' A' ' 17' ' ' LEU . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' SER . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' GLY . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p -121.96 150.08 42.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.619 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.619 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.9 129.66 2.08 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.149 0.906 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -116.49 67.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CGU . . . . . 0.437 ' CD1' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.437 ' H ' ' CD1' ' A' ' 32' ' ' CGU . 3.3 t70 -162.47 34.66 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.109 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -67.57 -175.75 0.55 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' A' ' 32' ' ' CGU . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -128.49 145.48 51.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.646 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.646 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -42.36 129.3 3.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.712 1.258 . . . . 0.0 109.673 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -98.45 33.39 2.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CGU . . . . . 0.429 ' CD2' HH11 ' A' ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.9 50.74 0.9 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 111.347 -2.661 . . . . 0.0 107.327 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 117.244 -1.36 . . . . 0.0 111.679 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p -124.7 176.95 6.24 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.835 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' CB ' HD21 ' A' ' 17' ' ' LEU . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p -114.93 151.3 34.29 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.578 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.578 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -39.99 124.64 1.83 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.426 1.079 . . . . 0.0 109.974 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' HH21 ' A' ' 18' ' ' ARG . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -92.84 59.37 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.37 49.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.781 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.303 -1.332 . . . . 0.0 110.83 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.71 -178.65 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 125.01 1.444 . . . . 0.0 113.637 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.48 128.11 5.12 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.679 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.679 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -46.01 129.26 9.69 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.577 1.173 . . . . 0.0 108.609 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' NH1' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -92.9 31.37 1.41 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 1.7 m-20 -100.15 50.93 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 112.167 -2.288 . . . . 0.0 108.293 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p -58.37 179.89 0.07 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 124.899 1.374 . . . . 0.0 112.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -134.45 152.99 52.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.711 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.711 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -46.12 129.77 10.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.566 1.166 . . . . 0.0 108.897 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -86.75 51.4 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.6 37.23 1.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.597 -1.668 . . . . 0.0 108.858 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -121.96 176.39 5.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.274 0.984 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' CB ' HD21 ' A' ' 17' ' ' LEU . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.53 144.96 41.13 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.601 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.601 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -39.69 123.97 1.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.196 0.935 . . . . 0.0 110.124 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 25' ' ' GLN . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 22' ' ' GLY . 13.5 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.53 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.14 39.98 1.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.65 30.92 2.83 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.33 -1.795 . . . . 0.0 109.124 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p -114.74 178.8 4.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 123.914 0.759 . . . . 0.0 110.506 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' CB ' HD21 ' A' ' 17' ' ' LEU . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -117.69 147.49 42.88 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.657 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.657 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -47.49 128.03 11.9 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -93.15 35.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CGU . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.58 41.91 1.08 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.809 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' CGU . 10.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.991 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p -52.58 174.07 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.624 1.203 . . . . 0.0 113.223 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p -114.34 144.5 43.17 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.659 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.659 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.1 130.55 6.07 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.297 0.998 . . . . 0.0 109.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -95.54 38.57 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.4 42.07 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 115.703 -2.094 . . . . 0.0 109.967 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 14.8 p -45.42 169.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.77 1.294 . . . . 0.0 114.442 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' HG3' HD21 ' A' ' 17' ' ' LEU . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p -121.7 148.59 44.4 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.617 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.617 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -41.48 124.06 2.32 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.188 0.93 . . . . 0.0 109.34 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' NE ' HD11 ' A' ' 28' ' ' ILE . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 17' ' ' LEU . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.79 38.59 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 53.33 36.03 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.936 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 116.397 -1.763 . . . . 0.0 108.509 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p -103.36 179.25 4.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.12 0.888 . . . . 0.0 110.845 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HA ' ' C ' ' A' ' 10' ' ' HYP . 0.8 OUTLIER -148.58 124.72 10.77 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.663 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.663 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -47.39 119.81 2.88 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -87.32 47.36 1.49 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -122.82 56.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.055 -1.43 . . . . 0.0 107.282 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.991 -179.841 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p -126.37 171.76 10.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.64 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 HH21 ' CD1' ' A' ' 32' ' ' CGU . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p -116.83 148.04 41.6 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.582 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.582 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -39.91 122.64 1.49 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.246 0.966 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' HD11 ' A' ' 28' ' ' ILE . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -92.14 40.69 1.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CGU . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 t70 52.76 35.44 18.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.101 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 32' ' ' CGU . 93.2 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.556 -1.688 . . . . 0.0 108.137 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.21 171.94 12.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.826 0.704 . . . . 0.0 112.678 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p -110.96 149.16 31.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.617 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.617 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -39.97 126.5 2.06 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.459 1.099 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' NE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.543 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -88.67 43.75 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.56 34.89 0.88 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.342 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 116.017 -1.944 . . . . 0.0 109.832 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p -114.92 179.08 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.507 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' C ' ' A' ' 10' ' ' HYP . 0.8 OUTLIER -159.99 130.86 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.646 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.646 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -40.08 127.68 2.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.581 1.176 . . . . 0.0 110.414 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -95.78 45.02 1.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.26 43.93 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.638 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.387 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.903 0.382 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p -127.18 175.6 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.691 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -111.93 149.66 31.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.594 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.594 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -39.77 126.22 1.93 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.968 1.417 . . . . 0.0 110.622 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -89.26 44.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.45 32.54 3.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.085 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.498 1.941 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.262 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 9.9 p -52.8 175.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p -137.28 143.84 42.38 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.678 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.678 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.84 130.7 25.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 22' ' ' GLY . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.467 HD11 ' HE ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -93.96 42.98 1.1 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -141.54 34.58 1.64 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.527 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 116.022 -1.942 . . . . 0.0 108.415 -179.822 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p -117.25 177.92 4.55 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.804 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.573 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.11 130.51 5.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.683 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.683 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -40.03 127.25 2.16 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.723 1.264 . . . . 0.0 110.758 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -95.69 52.8 1.38 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.71 56.02 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.552 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 116.783 -1.579 . . . . 0.0 109.525 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p -60.21 -178.75 0.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.805 1.316 . . . . 0.0 111.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.86 145.41 44.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HYP . . . . . 0.661 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HYP . . . . . 0.661 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -50.15 132.45 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 25' ' ' GLN . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 30.3 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -95.84 50.28 1.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CGU . . . . . 0.456 ' CG ' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 32' ' ' CGU . 0.1 OUTLIER -126.89 32.99 5.01 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.671 -2.059 . . . . 0.0 106.081 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.384 -1.769 . . . . 0.0 111.319 -179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.502 2.168 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p . . . . . 0 N--CA 1.501 2.089 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 . . . . . 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' OE1' ' SG ' ' A' ' 19' ' ' CYS . 1.5 mt-30 -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p . . . . . 0 N--CA 1.502 2.165 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p . . . . . 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.807 0.337 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.44 ' CB ' HD21 ' A' ' 17' ' ' LEU . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' SER . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' GLY . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.504 2.266 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.834 0.35 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 N--CA 1.498 1.935 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.493 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 . . . . . 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' CB ' HD21 ' A' ' 17' ' ' LEU . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 . . . . . 0 N--CA 1.503 2.208 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' HH21 ' A' ' 18' ' ' ARG . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 . . . . . 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.501 2.123 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 . . . . . 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.407 ' CB ' HD21 ' A' ' 17' ' ' LEU . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 25' ' ' GLN . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 22' ' ' GLY . 4.9 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.53 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.874 0.368 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.413 ' CB ' HD21 ' A' ' 17' ' ' LEU . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p . . . . . 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.512 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 . . . . . 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 . . . . . 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.502 2.152 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.58 ' HG3' HD21 ' A' ' 17' ' ' LEU . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 . . . . . 0 N--CA 1.502 2.167 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' NE ' HD11 ' A' ' 28' ' ' ILE . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 17' ' ' LEU . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.074 0.464 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 . . . . . 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p . . . . . 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.504 2.252 0 N-CA-C 111.49 0.181 . . . . 0.0 111.49 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' HD11 ' A' ' 28' ' ' ILE . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 . . . . . 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 112.678 0.621 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p . . . . . 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 119.306 -0.378 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.562 ' NE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.543 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 . . . . . 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 120.913 0.387 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 N--CA 1.504 2.238 0 CA-C-O 119.473 -0.298 . . . . 0.0 110.414 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 . . . . . 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 120.755 0.312 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.691 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p . . . . . 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 N--CA 1.502 2.167 0 CA-C-O 119.342 -0.361 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.54 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 . . . . . 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 22' ' ' GLY . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.467 HD11 ' HE ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 . . . . . 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.573 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 N--CA 1.501 2.08 0 CA-C-O 119.474 -0.298 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p . . . . . 0 N--CA 1.5 2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 111.884 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 25' ' ' GLN . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 29.7 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 6.5 p -53.86 177.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 124.907 1.379 . . . . 0.0 113.988 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.91 159.82 14.78 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.936 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.12 173.81 15.17 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 107.93 -2.068 . . . . 0.0 107.93 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -70.41 83.26 0.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.672 0.748 . . . . 0.0 110.009 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.79 -6.36 0.17 Allowed Glycine 0 N--CA 1.494 2.507 0 CA-C-N 114.252 -1.34 . . . . 0.0 110.736 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.32 147.45 49.72 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.95 -169.87 2.2 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.58 0.55 . . . . 0.0 112.432 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.4 p -123.87 147.03 47.99 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.662 -1.154 . . . . 0.0 111.998 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.675 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.675 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -48.95 129.88 17.75 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -54.44 138.31 40.36 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.853 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.3 m -56.09 172.7 0.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 113.558 -1.655 . . . . 0.0 112.769 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.86 127.79 31.92 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.524 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.98 -27.64 19.32 Favored Glycine 0 N--CA 1.483 1.806 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.054 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.25 165.79 12.42 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.646 1.212 . . . . 0.0 113.881 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -141.16 148.97 40.86 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 111.781 -2.463 . . . . 0.0 106.099 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.0 t -74.28 99.03 3.35 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.475 1.11 . . . . 0.0 113.188 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.491 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -77.12 110.39 3.01 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 162.02 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 124.411 0.712 . . . . 0.0 111.442 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 136.83 -175.39 21.09 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -132.16 115.84 15.32 Favored Pre-proline 0 N--CA 1.491 1.617 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -72.72 140.69 68.25 Favored 'Cis proline' 0 N--CA 1.491 1.349 0 O-C-N 122.599 0.789 . . . . 0.0 111.977 -5.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -59.96 150.57 28.52 Favored 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt -160.84 134.7 6.91 Favored 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 120.398 -0.521 . . . . 0.0 111.829 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 72.9 m -75.19 147.74 40.14 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.514 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.93 -174.99 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.07 137.88 13.55 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 120.2 -1.0 . . . . 0.0 111.86 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.97 -44.29 22.7 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -88.13 28.95 0.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.47 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -103.03 36.36 2.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.104 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.352 -1.785 . . . . 0.0 109.14 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.4 p -56.3 178.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 125.053 1.471 . . . . 0.0 113.133 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.4 m -103.83 149.33 25.15 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.318 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.53 175.27 25.49 Favored Glycine 0 N--CA 1.497 2.721 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 44.4 ttp85 -67.1 92.03 0.24 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.75 -10.82 0.81 Allowed Glycine 0 N--CA 1.492 2.388 0 CA-C-N 114.212 -1.358 . . . . 0.0 110.035 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 m -119.05 145.51 45.83 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.32 -173.35 4.66 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 123.955 0.785 . . . . 0.0 111.069 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 10' ' ' HYP . 22.6 p -114.55 138.73 50.27 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.411 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.667 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.667 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -51.35 135.22 27.31 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 m -58.58 137.09 57.68 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 118.42 -1.312 . . . . 0.0 110.69 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 64.9 m -55.16 172.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.412 -1.722 . . . . 0.0 112.656 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 41.4 ttm -54.76 130.62 41.41 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 114.82 -1.082 . . . . 0.0 111.355 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.55 -26.13 23.15 Favored Glycine 0 N--CA 1.487 2.035 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.186 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.0 mt -89.77 164.64 14.57 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 122.36 1.076 . . . . 0.0 112.945 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -145.34 147.48 32.35 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 112.345 -2.207 . . . . 0.0 105.296 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' A' ' 25' ' ' GLN . 1.8 t -79.59 112.78 17.18 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.526 1.141 . . . . 0.0 111.643 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 28' ' ' ILE . . . -103.87 157.86 17.18 Favored Glycine 0 N--CA 1.499 2.845 0 O-C-N 123.595 0.559 . . . . 0.0 113.185 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.445 ' CD ' ' H ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER 71.43 -163.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 125.297 1.233 . . . . 0.0 113.17 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.445 ' H ' ' CD ' ' A' ' 21' ' ' ARG . . . -133.34 -48.69 0.09 OUTLIER Glycine 0 N--CA 1.498 2.781 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -160.08 129.5 3.25 Favored Pre-proline 0 N--CA 1.495 1.81 0 C-N-CA 120.264 -0.574 . . . . 0.0 111.168 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.3 Cg_endo -71.08 109.17 0.91 Allowed 'Cis proline' 0 N--CA 1.487 1.14 0 N-CA-C 108.664 -1.321 . . . . 0.0 108.664 -16.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' OE1' ' SG ' ' A' ' 19' ' ' CYS . 1.5 mt-30 -49.65 158.82 0.42 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -160.83 126.98 3.97 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 113.991 -1.459 . . . . 0.0 111.763 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 63.2 m -72.15 148.69 45.41 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 121.372 0.605 . . . . 0.0 110.404 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 20' ' ' GLY . 0.1 OUTLIER -137.04 -169.93 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 179.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -102.67 136.7 12.98 Favored Glycine 0 N--CA 1.488 2.1 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.535 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.13 24.77 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.77 32.19 0.81 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.619 -1.628 . . . . 0.0 109.527 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -106.92 48.02 0.86 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 113.076 -1.875 . . . . 0.0 108.052 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.496 1.853 0 CA-C-O 116.5 -1.714 . . . . 0.0 109.234 -179.885 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 27.0 p -54.85 178.56 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 113.655 -1.611 . . . . 0.0 114.857 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.65 144.61 36.17 Favored 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 114.336 -1.302 . . . . 0.0 107.827 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.92 175.66 33.99 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -67.49 96.06 0.5 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 148.69 -7.92 0.96 Allowed Glycine 0 N--CA 1.495 2.567 0 CA-C-N 113.69 -1.596 . . . . 0.0 110.143 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.8 m -125.97 139.2 53.63 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -169.57 0.97 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 123.859 0.725 . . . . 0.0 110.689 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -123.96 150.1 45.18 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 124.222 0.951 . . . . 0.0 112.471 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.691 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.691 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -44.57 130.5 6.81 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.609 1.193 . . . . 0.0 109.16 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 m -55.33 137.9 46.74 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.483 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -55.32 165.87 0.69 Allowed 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 113.472 -1.694 . . . . 0.0 112.349 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.8 ttp -53.48 129.82 33.62 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.205 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.34 -31.06 9.15 Favored Glycine 0 N--CA 1.484 1.854 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.881 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.9 mt -84.9 165.16 17.9 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.947 0.879 . . . . 0.0 112.536 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -138.75 139.67 38.4 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 113.0 -1.909 . . . . 0.0 105.867 179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 17.7 t -72.39 99.33 2.42 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.93 1.394 . . . . 0.0 113.438 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.09 85.1 1.53 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -59.14 -23.6 62.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.862 0.977 . . . . 0.0 111.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.47 154.37 38.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -79.55 135.18 56.96 Favored Pre-proline 0 N--CA 1.495 1.816 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.185 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -71.02 130.41 18.02 Favored 'Cis proline' 0 N--CA 1.492 1.418 0 O-C-N 122.808 0.899 . . . . 0.0 111.501 -1.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -59.01 105.02 0.28 Allowed 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -161.07 154.67 22.01 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.032 -0.986 . . . . 0.0 112.622 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.4 m -81.76 144.71 30.9 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -127.0 -167.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -114.17 131.7 10.05 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 120.749 -0.739 . . . . 0.0 113.637 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -79.41 -47.07 16.35 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.02 59.09 3.51 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -158.28 52.11 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.895 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 116.396 -1.764 . . . . 0.0 108.584 179.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.699 0.285 . . . . 0.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 22.9 p -119.83 175.26 5.98 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 115.003 -0.999 . . . . 0.0 110.681 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 t -106.57 153.3 22.55 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.516 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.59 178.49 31.31 Favored Glycine 0 N--CA 1.496 2.665 0 O-C-N 124.049 0.843 . . . . 0.0 111.061 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.44 ' CB ' HD21 ' A' ' 17' ' ' LEU . 61.7 ttp85 -76.63 78.09 3.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 124.651 0.854 . . . . 0.0 109.341 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 7' ' ' SER . . . 166.78 0.68 0.04 OUTLIER Glycine 0 N--CA 1.492 2.372 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.827 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.407 ' H ' ' H ' ' A' ' 6' ' ' GLY . 1.5 p -145.01 142.17 29.56 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.04 -168.46 0.29 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.057 -0.974 . . . . 0.0 113.111 -179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.7 p -121.96 150.08 42.54 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 113.823 -1.535 . . . . 0.0 110.239 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.619 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.619 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -39.9 129.66 2.08 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 124.149 0.906 . . . . 0.0 109.896 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 m -55.47 138.19 46.82 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.681 -1.208 . . . . 0.0 110.834 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.77 170.36 0.41 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.595 -1.639 . . . . 0.0 112.417 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 tpp -53.25 131.33 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.262 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.58 -29.09 12.68 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -91.06 166.33 13.05 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 122.649 1.214 . . . . 0.0 113.391 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.432 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 9.8 ptt180 -141.01 149.72 42.11 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 111.621 -2.536 . . . . 0.0 106.088 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 t -75.69 97.08 3.73 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.611 1.195 . . . . 0.0 112.68 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.443 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.68 91.93 0.59 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.26 -20.16 51.91 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 125.195 1.174 . . . . 0.0 113.217 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 140.0 48.22 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.711 -1.355 . . . . 0.0 109.711 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -79.75 136.61 54.96 Favored Pre-proline 0 N--CA 1.494 1.764 0 CA-C-O 118.933 -0.556 . . . . 0.0 110.739 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -69.43 128.49 12.3 Favored 'Cis proline' 0 N--CA 1.491 1.34 0 O-C-N 122.82 0.905 . . . . 0.0 110.913 -1.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -53.4 119.66 5.1 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.344 1.027 . . . . 0.0 109.624 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -160.73 151.74 18.8 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 124.749 1.28 . . . . 0.0 110.619 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 80.7 m -82.38 148.28 28.34 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.538 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.12 -175.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.89 133.45 11.35 Favored Glycine 0 N--CA 1.486 2.003 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.269 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.432 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -83.33 -46.34 12.72 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -116.49 67.27 0.72 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.412 -1.722 . . . . 0.0 107.289 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . 0.437 ' CD1' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.437 ' H ' ' CD1' ' A' ' 32' ' ' CGU . 3.3 t70 -162.47 34.66 0.11 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.041 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.4 t . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.643 -1.646 . . . . 0.0 109.109 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 5.5 p -67.57 -175.75 0.55 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.952 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -105.13 149.81 25.57 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.197 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -104.26 175.48 22.88 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.429 HH11 ' CD2' ' A' ' 32' ' ' CGU . 0.0 OUTLIER -62.64 106.68 0.82 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.52 -11.41 6.37 Favored Glycine 0 N--CA 1.497 2.74 0 CA-C-N 113.659 -1.61 . . . . 0.0 112.151 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.3 m -110.83 141.16 44.58 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' NH1' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -75.83 -171.35 1.58 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 123.587 0.554 . . . . 0.0 111.08 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.7 p -128.49 145.48 51.1 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.636 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.646 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.646 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -42.36 129.3 3.89 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 124.712 1.258 . . . . 0.0 109.673 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -52.54 140.22 23.42 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 123.999 0.812 . . . . 0.0 111.893 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.0 m -56.7 174.18 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.479 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -57.18 127.86 34.08 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.307 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.09 -27.52 19.61 Favored Glycine 0 N--CA 1.485 1.904 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.62 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.26 163.8 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.107 0.956 . . . . 0.0 112.375 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -143.37 149.72 38.12 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 112.654 -2.066 . . . . 0.0 106.681 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -75.07 103.91 5.44 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.805 1.315 . . . . 0.0 113.965 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.34 121.68 5.51 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.31 157.13 6.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.634 0.843 . . . . 0.0 112.727 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 155.04 -162.88 31.15 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -160.49 102.78 1.35 Allowed Pre-proline 0 N--CA 1.496 1.828 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.258 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.23 140.51 52.27 Favored 'Cis proline' 0 N--CA 1.489 1.208 0 O-C-N 122.513 0.744 . . . . 0.0 110.479 -6.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.493 ' H ' ' NH1' ' A' ' 8' ' ' ARG . 50.4 mt-30 -57.7 175.69 0.17 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 124.118 0.886 . . . . 0.0 110.871 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -160.27 126.6 4.2 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.818 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 66.0 m -73.65 144.95 45.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 121.469 0.652 . . . . 0.0 109.547 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' HD13 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -133.47 -170.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 103.601 -2.74 . . . . 0.0 103.601 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.76 141.67 15.44 Favored Glycine 0 N--CA 1.486 2.021 0 C-N-CA 120.001 -1.095 . . . . 0.0 111.904 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.26 -42.04 60.27 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -98.45 33.39 2.25 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.229 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . 0.429 ' CD2' HH11 ' A' ' 5' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -113.9 50.74 0.9 Allowed 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 111.347 -2.661 . . . . 0.0 107.327 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.5 2.026 0 CA-C-O 117.244 -1.36 . . . . 0.0 111.679 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.437 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 21.3 p -124.7 176.95 6.24 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.835 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.4 m -107.22 145.22 32.91 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.463 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.41 172.97 30.81 Favored Glycine 0 N--CA 1.497 2.701 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' CB ' HD21 ' A' ' 17' ' ' LEU . 24.6 ttp85 -69.06 91.88 0.51 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.47 -6.9 0.23 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.152 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.4 m -135.32 142.3 45.78 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.51 -169.03 1.31 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.667 0.604 . . . . 0.0 111.248 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 10.6 p -114.93 151.3 34.29 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.738 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.578 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.578 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -39.99 124.64 1.83 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 124.426 1.079 . . . . 0.0 109.974 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -49.27 140.59 9.71 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.915 0.864 . . . . 0.0 112.411 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.2 m -57.85 170.19 0.65 Allowed 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 112.97 -1.923 . . . . 0.0 113.167 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.1 ttm -55.36 127.29 28.79 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.5 -27.83 17.52 Favored Glycine 0 N--CA 1.483 1.807 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.737 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.5 OUTLIER -94.66 167.59 11.37 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.472 1.13 . . . . 0.0 112.937 -179.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -140.9 149.03 41.38 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 111.988 -2.369 . . . . 0.0 106.308 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 9.1 t -73.81 96.78 2.62 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.857 1.348 . . . . 0.0 113.848 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.494 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.01 79.49 1.7 Allowed Glycine 0 N--CA 1.495 2.61 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -73.56 21.96 0.08 Allowed 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -77.31 -118.29 0.18 Allowed Glycine 0 N--CA 1.497 2.703 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -159.99 121.06 1.74 Allowed Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -67.67 142.18 62.49 Favored 'Cis proline' 0 N--CA 1.49 1.298 0 O-C-N 122.623 0.801 . . . . 0.0 110.798 -3.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -64.86 114.94 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 mttp -161.19 154.71 21.8 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.226 0.954 . . . . 0.0 111.083 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 89.6 m -80.95 146.35 30.79 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.519 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.21 -174.28 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.99 139.63 14.57 Favored Glycine 0 N--CA 1.484 1.845 0 C-N-CA 119.574 -1.298 . . . . 0.0 112.37 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.406 ' HA ' HH21 ' A' ' 18' ' ' ARG . . . -86.38 -43.04 13.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -92.84 59.37 3.2 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -126.37 49.74 1.98 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.626 -1.625 . . . . 0.0 107.781 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.501 2.092 0 CA-C-O 117.303 -1.332 . . . . 0.0 110.83 -179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 9.1 p -57.71 -178.65 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 125.01 1.444 . . . . 0.0 113.637 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -104.55 152.8 21.97 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 114.58 -1.191 . . . . 0.0 109.245 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.5 175.84 24.85 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.0 ttp180 -69.05 92.81 0.54 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.578 0.704 . . . . 0.0 109.718 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.73 -8.97 3.96 Favored Glycine 0 N--CA 1.496 2.638 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.543 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -95.43 157.8 15.74 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -76.46 -162.33 0.24 Allowed 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.112 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -159.48 128.11 5.12 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.043 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.679 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.679 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -46.01 129.26 9.69 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.577 1.173 . . . . 0.0 108.609 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.44 141.3 25.28 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.83 -0.748 . . . . 0.0 112.169 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 67.3 m -57.58 169.76 0.64 Allowed 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.105 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 1.2 ttp -57.45 130.93 48.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.055 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.72 18.68 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.3 mt -92.67 167.31 11.98 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.026 0.917 . . . . 0.0 111.314 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' NH1' ' HA ' ' A' ' 33' ' ' ASP . 0.1 OUTLIER -141.82 144.72 34.05 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.6 t -78.38 107.37 10.96 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.7 100.59 2.3 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 106.005 -2.838 . . . . 0.0 106.005 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 10.5 ttt180 -62.28 153.44 30.76 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 124.281 0.636 . . . . 0.0 112.495 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 160.99 -147.5 14.26 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 108.596 -1.801 . . . . 0.0 108.596 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -160.1 110.83 1.41 Allowed Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -67.13 140.54 52.05 Favored 'Cis proline' 0 N--CA 1.489 1.232 0 O-C-N 122.6 0.79 . . . . 0.0 110.974 -8.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -60.03 151.87 25.39 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -150.71 126.82 10.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 68.6 m -73.01 145.26 46.78 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.225 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.24 -168.58 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.76 144.53 16.79 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.308 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.3 -28.06 69.75 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.603 -0.798 . . . . 0.0 109.903 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -92.9 31.37 1.41 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.971 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' HA ' ' NH1' ' A' ' 18' ' ' ARG . 1.7 m-20 -100.15 50.93 0.9 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.495 1.791 0 CA-C-N 112.167 -2.288 . . . . 0.0 108.293 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 10.7 p -58.37 179.89 0.07 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 124.899 1.374 . . . . 0.0 112.676 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 m -103.82 151.72 22.75 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -102.96 171.12 20.48 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -67.09 94.8 0.36 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.857 0.837 . . . . 0.0 109.332 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 146.67 -10.38 1.44 Allowed Glycine 0 N--CA 1.495 2.612 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.536 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.4 m -119.81 145.68 46.4 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.74 -167.78 0.9 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 123.772 0.67 . . . . 0.0 110.691 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -134.45 152.99 52.14 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.193 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.711 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.711 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -46.12 129.77 10.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 124.566 1.166 . . . . 0.0 108.897 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.1 m -53.37 138.55 32.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 124.029 0.831 . . . . 0.0 111.273 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -53.73 165.71 0.4 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 113.247 -1.797 . . . . 0.0 112.748 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.5 ttp -56.69 126.45 26.82 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.154 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 110.39 -30.26 8.39 Favored Glycine 0 N--CA 1.485 1.932 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.6 mt -89.1 167.92 12.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 122.078 0.942 . . . . 0.0 112.67 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -141.0 139.11 34.12 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 112.959 -1.928 . . . . 0.0 106.141 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 11.7 t -72.61 98.08 2.27 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.771 1.294 . . . . 0.0 112.337 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -80.81 98.54 1.82 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 115.03 6.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 124.362 0.683 . . . . 0.0 109.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.21 -142.52 3.92 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 8.9 t-20 -160.36 97.84 1.44 Allowed Pre-proline 0 N--CA 1.494 1.729 0 C-N-CA 120.621 -0.431 . . . . 0.0 110.217 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 18.4 Cg_endo -72.39 134.25 33.29 Favored 'Cis proline' 0 N--CA 1.491 1.366 0 O-C-N 122.442 0.706 . . . . 0.0 110.824 -4.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -50.86 157.36 0.82 Allowed 'General case' 0 N--CA 1.506 2.344 0 O-C-N 124.359 1.037 . . . . 0.0 111.067 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.8 mtmm -160.62 140.33 10.96 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 123.882 0.739 . . . . 0.0 112.002 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.1 m -76.75 143.24 40.04 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.17 -167.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.78 137.46 14.29 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.576 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.427 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -78.94 -39.22 35.17 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -86.75 51.4 2.23 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 114.189 -1.369 . . . . 0.0 108.428 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -98.6 37.23 1.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 116.597 -1.668 . . . . 0.0 108.858 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.6 p -121.96 176.39 5.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 124.274 0.984 . . . . 0.0 110.08 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.2 t -107.85 144.21 35.37 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.719 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.96 177.95 43.38 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.407 ' CB ' HD21 ' A' ' 17' ' ' LEU . 16.6 ttp180 -74.92 84.02 2.22 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.802 0.81 . . . . 0.0 109.263 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.52 -1.59 0.08 OUTLIER Glycine 0 N--CA 1.494 2.547 0 CA-C-N 114.085 -1.416 . . . . 0.0 110.539 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.6 m -136.43 150.7 48.88 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.69 -172.13 4.01 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.9 p -112.53 144.96 41.13 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 113.843 -1.526 . . . . 0.0 110.29 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.601 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.601 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -39.69 123.97 1.62 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.196 0.935 . . . . 0.0 110.124 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -47.77 139.7 7.18 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.722 0.772 . . . . 0.0 112.259 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.1 m -58.76 172.55 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 113.315 -1.766 . . . . 0.0 113.34 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.8 ttm -54.4 127.28 26.78 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.039 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.1 29.57 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 114.331 -1.304 . . . . 0.0 111.414 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.49 166.09 12.43 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.574 1.178 . . . . 0.0 113.508 -179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.05 145.86 36.42 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 111.684 -2.507 . . . . 0.0 105.954 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.5 t -74.25 94.88 2.55 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.887 1.367 . . . . 0.0 112.732 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.415 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.09 99.95 0.99 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 15.9 ttp180 -60.35 149.59 33.28 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 124.218 0.599 . . . . 0.0 111.092 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 25' ' ' GLN . . . 169.51 -156.0 26.61 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 9.0 t-20 -154.74 104.89 2.32 Favored Pre-proline 0 N--CA 1.495 1.821 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.183 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 11.9 Cg_endo -70.8 127.07 11.18 Favored 'Cis proline' 0 N--CA 1.49 1.32 0 O-C-N 122.432 0.701 . . . . 0.0 110.733 -7.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HB3' ' H ' ' A' ' 22' ' ' GLY . 4.9 pt20 -57.83 162.65 3.07 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 123.714 0.634 . . . . 0.0 111.098 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -160.75 148.26 15.75 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.637 . . . . 0.0 110.81 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.88 147.7 29.17 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.53 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.63 -176.13 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 104.411 -2.441 . . . . 0.0 104.411 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 140.36 15.01 Favored Glycine 0 N--CA 1.483 1.823 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.847 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.04 -43.88 17.35 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -93.14 39.98 1.05 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 113.482 -1.69 . . . . 0.0 107.945 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -136.65 30.92 2.83 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.429 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.33 -1.795 . . . . 0.0 109.124 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.3 p -114.74 178.8 4.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 123.914 0.759 . . . . 0.0 110.506 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.84 148.49 39.88 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-N 114.74 -1.118 . . . . 0.0 109.334 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.82 173.95 35.49 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 124.183 0.927 . . . . 0.0 111.195 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.413 ' CB ' HD21 ' A' ' 17' ' ' LEU . 59.7 ttp85 -66.81 86.26 0.13 Allowed 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.807 0.813 . . . . 0.0 111.456 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.17 -7.19 0.1 Allowed Glycine 0 N--CA 1.495 2.571 0 CA-C-N 113.678 -1.601 . . . . 0.0 110.051 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 56.3 p -133.09 140.32 47.6 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.1 -166.82 0.53 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 124.052 0.845 . . . . 0.0 112.222 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.1 p -117.69 147.49 42.88 Favored 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 114.377 -1.283 . . . . 0.0 110.965 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.657 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.657 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -47.49 128.03 11.9 Favored 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -52.75 139.94 25.19 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.415 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.1 m -58.15 169.81 0.77 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.908 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.6 ttm -53.56 129.12 31.6 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.814 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.13 -28.17 17.14 Favored Glycine 0 N--CA 1.485 1.94 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -93.23 166.08 12.49 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 122.581 1.181 . . . . 0.0 113.376 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -141.06 148.53 40.34 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 111.748 -2.478 . . . . 0.0 106.055 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.0 t -74.8 97.03 3.18 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 124.676 1.235 . . . . 0.0 113.116 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.19 94.68 0.55 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 108.423 -1.871 . . . . 0.0 108.423 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -59.0 -22.91 61.37 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 125.166 1.157 . . . . 0.0 113.086 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -55.04 135.62 46.88 Favored Glycine 0 N--CA 1.498 2.767 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -79.7 135.66 56.0 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 124.097 0.528 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.63 127.7 12.16 Favored 'Cis proline' 0 N--CA 1.492 1.417 0 O-C-N 122.816 0.903 . . . . 0.0 111.102 -0.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -51.26 124.07 10.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.314 1.009 . . . . 0.0 110.231 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -160.65 145.08 14.05 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 124.528 1.142 . . . . 0.0 110.427 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.9 m -79.28 146.62 32.88 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.512 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -132.97 -175.86 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 179.887 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.8 138.19 13.74 Favored Glycine 0 N--CA 1.485 1.906 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.309 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.21 -45.61 17.74 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -93.15 35.9 1.06 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.727 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . 0.405 ' C ' ' H ' ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.58 41.91 1.08 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-N 113.678 -1.601 . . . . 0.0 107.809 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 32' ' ' CGU . 10.2 p . . . . . 0 N--CA 1.495 1.82 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.991 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.9 p -52.58 174.07 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 124.624 1.203 . . . . 0.0 113.223 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.5 m -101.07 147.82 25.77 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.689 -1.141 . . . . 0.0 108.823 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.17 173.64 31.77 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.1 tmm_? -69.25 90.76 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.785 0.803 . . . . 0.0 109.685 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 152.29 -6.99 0.52 Allowed Glycine 0 N--CA 1.493 2.461 0 CA-C-N 113.16 -1.836 . . . . 0.0 110.345 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.8 m -122.6 145.35 48.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.08 -174.22 4.96 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.9 p -114.34 144.5 43.17 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.421 -1.263 . . . . 0.0 111.676 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.659 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.659 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.1 130.55 6.07 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 124.297 0.998 . . . . 0.0 109.039 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -53.46 136.59 37.69 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.144 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.7 m -54.28 166.32 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.237 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.4 ttm -51.8 129.44 26.49 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.479 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.36 -27.05 22.3 Favored Glycine 0 N--CA 1.483 1.828 0 CA-C-N 114.454 -1.248 . . . . 0.0 110.864 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.21 163.15 15.53 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.808 0.813 . . . . 0.0 112.855 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HG3' HG12 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -138.76 140.6 38.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 179.544 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 8.3 t -72.16 99.98 2.46 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.837 1.336 . . . . 0.0 113.159 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -82.81 117.93 4.51 Favored Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.57 169.25 4.03 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.125 0.488 . . . . 0.0 111.647 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 149.59 -156.39 26.75 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 108.836 -1.706 . . . . 0.0 108.836 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 1.9 t30 -160.03 105.17 1.41 Allowed Pre-proline 0 N--CA 1.494 1.732 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 10.0 Cg_endo -68.18 141.14 59.13 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 O-C-N 122.695 0.84 . . . . 0.0 111.093 -6.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -59.36 164.32 3.39 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 123.86 0.725 . . . . 0.0 109.425 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -160.93 135.87 7.55 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.7 m -77.64 148.14 35.21 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.403 HG12 ' HG3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -128.67 -169.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.68 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -111.01 134.37 12.13 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.523 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.24 -43.52 94.67 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 48.0 t60 -95.54 38.57 1.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.558 -1.655 . . . . 0.0 106.975 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.4 42.07 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 115.703 -2.094 . . . . 0.0 109.967 -179.882 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.435 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 14.8 p -45.42 169.38 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 124.77 1.294 . . . . 0.0 114.442 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -93.7 162.9 13.75 Favored 'General case' 0 N--CA 1.501 2.101 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.591 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -177.68 15.56 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.58 ' HG3' HD21 ' A' ' 17' ' ' LEU . 17.6 mtp180 -63.68 102.62 0.46 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 114.906 -0.647 . . . . 0.0 109.504 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.71 -6.92 6.97 Favored Glycine 0 N--CA 1.498 2.826 0 O-C-N 123.958 0.786 . . . . 0.0 112.779 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.16 142.48 50.86 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -171.07 1.61 Allowed 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 12.5 p -121.7 148.59 44.4 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 114.038 -1.437 . . . . 0.0 110.905 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.617 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.617 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -41.48 124.06 2.32 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.188 0.93 . . . . 0.0 109.34 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -50.01 137.18 17.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 123.912 0.758 . . . . 0.0 111.967 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.8 m -54.39 169.27 0.2 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 113.234 -1.803 . . . . 0.0 112.961 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 12.2 ttm -56.13 126.87 27.94 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.843 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.8 -30.97 8.67 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.869 -1.292 . . . . 0.0 109.869 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -92.47 166.37 12.57 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 122.699 1.238 . . . . 0.0 112.997 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' NE ' HD11 ' A' ' 28' ' ' ILE . 5.7 ptm180 -141.74 148.79 39.56 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.465 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.6 t -75.31 97.04 3.48 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 124.838 1.336 . . . . 0.0 112.976 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -73.88 107.52 2.27 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.079 -1.609 . . . . 0.0 109.079 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.1 tpp180 -65.22 155.66 34.35 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.451 0.736 . . . . 0.0 110.712 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.43 -164.07 29.7 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 112.74 4.74 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -71.62 138.57 54.14 Favored 'Cis proline' 0 N--CA 1.49 1.286 0 O-C-N 122.49 0.732 . . . . 0.0 111.203 -7.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -57.73 156.18 9.02 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.813 0.696 . . . . 0.0 109.948 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -160.63 134.75 7.15 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.84 0.713 . . . . 0.0 110.718 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 73.6 m -79.52 148.27 31.87 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.608 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -134.74 -173.58 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 17' ' ' LEU . . . -99.98 140.62 15.04 Favored Glycine 0 N--CA 1.484 1.866 0 C-N-CA 119.661 -1.257 . . . . 0.0 111.342 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.77 -47.38 12.0 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -89.79 38.59 0.92 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.675 -1.602 . . . . 0.0 107.885 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.4 t70 53.33 36.03 21.81 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.936 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.0 t . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 116.397 -1.763 . . . . 0.0 108.509 -179.978 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 15.0 p -103.36 179.25 4.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 124.12 0.888 . . . . 0.0 110.845 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.7 t -104.83 147.83 27.3 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.348 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.84 170.84 23.22 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 107.352 -2.299 . . . . 0.0 107.352 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 7.8 ttm180 -67.06 92.15 0.24 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.677 0.751 . . . . 0.0 110.68 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.93 -9.16 2.26 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.237 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.72 157.51 17.02 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.11 -172.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 123.859 0.724 . . . . 0.0 111.765 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HA ' ' C ' ' A' ' 10' ' ' HYP . 0.8 OUTLIER -148.58 124.72 10.77 Favored 'General case' 0 C--N 1.307 -1.269 0 O-C-N 124.477 1.111 . . . . 0.0 111.107 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.663 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.663 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -47.39 119.81 2.88 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 m -47.88 140.2 6.92 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.2 m -59.97 175.72 0.37 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 112.413 -2.176 . . . . 0.0 112.989 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 40.4 tpp -56.83 128.58 37.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.02 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.91 -23.87 33.65 Favored Glycine 0 N--CA 1.485 1.934 0 CA-C-N 114.684 -1.143 . . . . 0.0 111.688 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 50.5 mt -92.67 165.94 12.72 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.086 0.946 . . . . 0.0 112.259 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -144.48 147.03 32.78 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 112.868 -1.969 . . . . 0.0 105.994 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.6 t -74.9 107.14 6.78 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 116.195 1.924 . . . . 0.0 116.195 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -84.97 108.67 3.2 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -64.17 125.98 26.25 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 124.749 0.911 . . . . 0.0 110.408 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -177.06 -172.27 41.48 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -136.87 105.66 8.9 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -73.56 142.29 74.32 Favored 'Cis proline' 0 N--CA 1.489 1.251 0 O-C-N 122.459 0.715 . . . . 0.0 111.423 -2.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -54.84 149.46 11.35 Favored 'General case' 0 N--CA 1.507 2.421 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -157.46 130.03 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 C-N-CA 119.59 -0.844 . . . . 0.0 112.783 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 83.7 m -73.07 142.94 47.59 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.867 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.86 -165.21 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 104.256 -2.498 . . . . 0.0 104.256 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.41 16.19 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 120.34 -0.933 . . . . 0.0 113.736 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.24 -35.58 21.48 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -87.32 47.36 1.49 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -122.82 56.74 1.14 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.055 -1.43 . . . . 0.0 107.282 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.0 t . . . . . 0 N--CA 1.495 1.798 0 CA-C-N 113.276 -1.784 . . . . 0.0 108.991 -179.841 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 8.1 p -126.37 171.76 10.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.64 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.05 168.94 9.96 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 123.914 0.759 . . . . 0.0 109.724 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.36 170.64 14.37 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 HH21 ' CD1' ' A' ' 32' ' ' CGU . 2.2 ttm180 -68.95 84.38 0.32 Allowed 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.843 0.83 . . . . 0.0 108.997 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 157.64 -7.62 0.2 Allowed Glycine 0 N--CA 1.493 2.491 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.001 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.2 p -136.5 135.99 39.02 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CD ' ' H ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -68.5 -169.8 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.495 1.122 . . . . 0.0 113.464 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 19.6 p -116.83 148.04 41.6 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.077 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.582 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.582 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -39.91 122.64 1.49 Allowed 'General case' 0 N--CA 1.504 2.252 0 O-C-N 124.246 0.966 . . . . 0.0 111.49 -179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -44.73 137.56 3.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 124.226 0.954 . . . . 0.0 112.925 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.8 m -55.43 168.39 0.39 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 113.692 -1.595 . . . . 0.0 113.185 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 3.5 ttp -56.07 128.32 34.81 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.309 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.04 -31.3 8.71 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 33.0 mt -88.32 166.87 13.99 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-O 122.322 1.058 . . . . 0.0 112.394 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' NE ' HD11 ' A' ' 28' ' ' ILE . 4.9 ptm180 -144.0 147.93 34.55 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 112.207 -2.27 . . . . 0.0 106.4 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.3 t -74.64 98.32 3.38 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 124.791 1.307 . . . . 0.0 111.946 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.521 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -72.55 132.72 18.5 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -25.12 147.23 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.554 ' HA2' ' CG ' ' A' ' 25' ' ' GLN . . . -67.56 48.62 0.31 Allowed Glycine 0 N--CA 1.494 2.527 0 CA-C-N 112.306 -2.225 . . . . 0.0 117.452 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.68 83.98 1.98 Allowed Pre-proline 0 C--N 1.305 -1.351 0 C-N-CA 120.105 -0.638 . . . . 0.0 110.219 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -82.52 115.96 4.1 Favored 'Cis proline' 0 N--CA 1.489 1.239 0 CA-C-O 118.012 -0.911 . . . . 0.0 110.128 -18.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.554 ' CG ' ' HA2' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -20.3 114.29 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.737 0 O-C-N 124.789 1.305 . . . . 0.0 113.509 179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.8 mttt -161.03 138.95 9.46 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 124.597 1.185 . . . . 0.0 113.023 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 69.4 m -79.72 149.62 31.12 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.684 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -136.85 -170.79 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 179.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.71 140.73 15.1 Favored Glycine 0 N--CA 1.486 2.02 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.299 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.56 -48.88 15.88 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -92.14 40.69 1.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.174 -1.83 . . . . 0.0 109.067 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . 0.589 ' O ' HG23 ' A' ' 34' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.3 t70 52.76 35.44 18.62 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.258 -1.337 . . . . 0.0 110.101 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 32' ' ' CGU . 93.2 t . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 116.556 -1.688 . . . . 0.0 108.137 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 26.5 p -130.21 171.94 12.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 123.826 0.704 . . . . 0.0 112.678 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -103.9 150.79 23.85 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.19 176.5 26.83 Favored Glycine 0 N--CA 1.498 2.807 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -69.79 88.42 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 122.025 0.917 . . . . 0.0 108.643 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.45 -6.2 0.56 Allowed Glycine 0 N--CA 1.494 2.502 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.319 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.0 m -127.24 144.08 51.11 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.37 -173.12 4.51 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.073 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 18.1 p -110.96 149.16 31.06 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.876 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.617 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.617 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -39.97 126.5 2.06 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.459 1.099 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.0 m -49.11 137.91 12.82 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.911 0.863 . . . . 0.0 112.557 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.0 m -54.79 166.58 0.47 Allowed 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 112.82 -1.991 . . . . 0.0 113.403 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 14.0 tmm? -54.71 124.75 17.4 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.528 -1.215 . . . . 0.0 110.915 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.63 -32.13 7.58 Favored Glycine 0 N--CA 1.484 1.858 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.6 mt -87.62 167.62 13.74 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.276 1.036 . . . . 0.0 112.062 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' NE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -142.7 152.51 42.45 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 112.361 -2.2 . . . . 0.0 105.31 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.8 t -80.5 101.83 9.35 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.221 0.951 . . . . 0.0 112.115 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.543 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -81.06 103.98 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -61.58 136.34 57.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.073 0.514 . . . . 0.0 111.101 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.21 -148.97 6.14 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -160.63 97.72 1.4 Allowed Pre-proline 0 N--CA 1.495 1.793 0 C-N-CA 120.026 -0.67 . . . . 0.0 110.395 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -69.6 139.81 56.33 Favored 'Cis proline' 0 N--CA 1.489 1.248 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 -5.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -57.92 166.39 1.5 Allowed 'General case' 0 N--CA 1.506 2.329 0 O-C-N 123.997 0.81 . . . . 0.0 109.892 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -160.36 136.69 8.71 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.276 0.36 . . . . 0.0 111.436 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 74.1 m -76.7 145.81 38.46 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.201 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -132.52 -168.31 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 104.335 -2.469 . . . . 0.0 104.335 179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.58 140.01 14.67 Favored Glycine 0 N--CA 1.488 2.109 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.583 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.49 -40.15 12.17 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -88.67 43.75 1.16 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.403 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -90.56 34.89 0.88 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.342 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 116.017 -1.944 . . . . 0.0 109.832 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 16.2 p -114.92 179.08 4.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.507 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -110.09 155.39 21.94 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.604 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.16 170.08 19.35 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 107.741 -2.143 . . . . 0.0 107.741 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -60.14 115.24 3.33 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 118.424 -1.31 . . . . 0.0 110.662 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 117.61 -22.02 10.28 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.0 m -83.47 159.99 21.62 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -75.77 -165.98 0.51 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.59 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' C ' ' A' ' 10' ' ' HYP . 0.8 OUTLIER -159.99 130.86 5.72 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.701 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.646 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.646 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -40.08 127.68 2.19 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 124.581 1.176 . . . . 0.0 110.414 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.5 m -55.91 139.76 45.03 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.379 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 m -60.42 172.11 0.94 Allowed 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.147 -1.388 . . . . 0.0 112.427 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 6.3 tpt -61.45 114.84 3.45 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.16 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 135.87 -46.5 1.03 Allowed Glycine 0 N--CA 1.479 1.513 0 N-CA-C 106.406 -2.678 . . . . 0.0 106.406 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.23 169.37 15.82 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 116.551 2.056 . . . . 0.0 116.551 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 30' ' ' ALA . 1.6 ptm180 -145.9 145.21 30.62 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 110.362 -3.108 . . . . 0.0 103.579 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.8 t -80.42 108.93 14.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.83 110.07 3.49 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 107.771 -2.132 . . . . 0.0 107.771 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.21 148.36 22.59 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.411 0.712 . . . . 0.0 111.541 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 169.12 -156.81 28.37 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -160.0 102.22 1.43 Allowed Pre-proline 0 N--CA 1.495 1.775 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -69.02 141.01 61.61 Favored 'Cis proline' 0 N--CA 1.489 1.219 0 O-C-N 122.677 0.83 . . . . 0.0 110.807 -3.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -57.29 156.15 7.98 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 47.3 mttm -153.04 128.94 10.25 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 62.8 m -73.26 148.76 43.33 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.892 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.53 -170.63 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 103.13 -2.915 . . . . 0.0 103.13 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.57 140.93 15.74 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.901 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . . . -89.31 -45.14 9.72 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -95.78 45.02 1.08 Allowed 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.013 -1.449 . . . . 0.0 107.492 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.26 43.93 1.17 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.638 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.501 2.115 0 CA-C-O 117.466 -1.254 . . . . 0.0 111.387 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.903 0.382 . . . . 0.0 110.439 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 20.3 p -127.18 175.6 8.02 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.86 149.15 25.34 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.87 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -100.26 176.43 27.9 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 17.3 ttp85 -73.29 83.13 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.95 -2.51 0.06 OUTLIER Glycine 0 N--CA 1.491 2.365 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.101 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.8 p -139.55 138.0 35.91 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.691 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.54 -175.97 1.45 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 124.032 0.833 . . . . 0.0 111.35 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.6 p -111.93 149.66 31.59 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.626 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.594 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.594 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -39.77 126.22 1.93 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.968 1.417 . . . . 0.0 110.622 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 m -48.98 140.64 8.71 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.743 0.783 . . . . 0.0 112.388 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.9 m -59.25 171.67 0.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 113.18 -1.827 . . . . 0.0 112.597 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.01 127.19 29.27 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.32 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 103.76 -27.12 21.01 Favored Glycine 0 N--CA 1.484 1.883 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -94.77 167.42 11.45 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 122.397 1.094 . . . . 0.0 113.219 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ptt180 -142.17 148.96 39.1 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 111.916 -2.402 . . . . 0.0 106.198 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.8 t -73.2 98.63 2.66 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 124.712 1.257 . . . . 0.0 113.395 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -76.03 88.69 0.88 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 108.579 -1.808 . . . . 0.0 108.579 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -62.6 -13.49 32.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 125.019 1.07 . . . . 0.0 112.456 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -66.3 153.59 51.99 Favored Glycine 0 N--CA 1.495 2.586 0 N-CA-C 108.794 -1.722 . . . . 0.0 108.794 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -79.71 136.77 54.96 Favored Pre-proline 0 N--CA 1.493 1.705 0 CA-C-O 119.024 -0.513 . . . . 0.0 110.935 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -70.95 136.25 40.37 Favored 'Cis proline' 0 N--CA 1.491 1.364 0 O-C-N 122.796 0.893 . . . . 0.0 110.256 -5.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -57.82 113.49 1.88 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 123.904 0.752 . . . . 0.0 109.485 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -161.0 152.78 19.59 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.828 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 77.6 m -80.92 148.56 29.8 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.54 ' O ' HD23 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -133.84 -174.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 105.181 -2.155 . . . . 0.0 105.181 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.85 135.88 12.42 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.705 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.83 -42.39 27.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -89.26 44.45 1.21 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 113.729 -1.578 . . . . 0.0 107.055 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -103.45 32.54 3.77 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.476 -1.238 . . . . 0.0 109.085 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.498 1.941 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.262 -179.871 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 11' ' ' HYP . 9.9 p -52.8 175.76 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.405 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.3 OUTLIER -98.53 168.87 9.91 Favored 'General case' 0 N--CA 1.504 2.226 0 CA-C-N 114.847 -1.069 . . . . 0.0 109.757 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -120.24 169.92 14.13 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 8.6 tmm_? -67.73 86.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.93 0.871 . . . . 0.0 109.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 156.52 -6.55 0.22 Allowed Glycine 0 N--CA 1.493 2.436 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.983 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.5 p -136.23 134.69 38.38 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.63 -154.6 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.3 p -137.28 143.84 42.38 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 113.605 -1.634 . . . . 0.0 112.806 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.678 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.678 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -50.84 130.7 25.53 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.7 m -57.35 137.84 55.61 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.5 -1.28 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 3' ' ' SER . 81.9 m -55.65 170.71 0.25 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 124.576 1.172 . . . . 0.0 113.107 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 2.2 tpp -52.79 130.62 33.46 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 114.496 -1.229 . . . . 0.0 111.411 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.04 -26.78 22.09 Favored Glycine 0 N--CA 1.486 1.986 0 CA-C-N 114.832 -1.077 . . . . 0.0 110.956 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -88.8 167.38 13.33 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 122.329 1.061 . . . . 0.0 112.882 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' A' ' 28' ' ' ILE . 3.7 ptm180 -144.34 144.84 31.64 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.437 -2.165 . . . . 0.0 106.03 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -74.71 99.52 3.72 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 124.736 1.272 . . . . 0.0 112.788 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.41 ' HA3' HD12 ' A' ' 28' ' ' ILE . . . -80.22 113.91 3.74 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.887 -1.285 . . . . 0.0 109.887 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.2 ttt-85 -66.82 143.59 56.8 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.17 0.51 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.433 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -176.37 -152.12 9.41 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.73 -1.748 . . . . 0.0 108.73 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.46 99.29 1.39 Allowed Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -69.67 138.26 47.88 Favored 'Cis proline' 0 N--CA 1.488 1.186 0 O-C-N 122.472 0.722 . . . . 0.0 111.198 -7.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' H ' ' A' ' 22' ' ' GLY . 8.3 mt-30 -54.1 166.61 0.36 Allowed 'General case' 0 N--CA 1.505 2.319 0 O-C-N 124.262 0.976 . . . . 0.0 109.958 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.72 135.91 7.8 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 123.22 0.325 . . . . 0.0 111.573 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 65.3 m -77.04 148.35 36.22 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.66 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.467 HD11 ' HE ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -133.91 -169.57 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 103.69 -2.707 . . . . 0.0 103.69 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -106.82 141.59 15.55 Favored Glycine 0 N--CA 1.485 1.954 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.294 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.84 -48.34 7.9 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -93.96 42.98 1.1 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 113.568 -1.651 . . . . 0.0 107.074 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -141.54 34.58 1.64 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 113.148 -1.842 . . . . 0.0 106.527 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.5 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 116.022 -1.942 . . . . 0.0 108.415 -179.822 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 24.5 p -117.25 177.92 4.55 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.804 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -110.23 151.35 27.45 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.04 171.67 27.33 Favored Glycine 0 N--CA 1.497 2.75 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 6.7 ttm180 -64.43 114.02 4.04 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.5 -12.49 18.66 Favored Glycine 0 N--CA 1.495 2.627 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 -179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.1 t -96.64 155.86 16.59 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.573 ' H ' ' NE ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.11 -167.36 0.21 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.11 130.51 5.5 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.533 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.683 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.683 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -40.03 127.25 2.16 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 124.723 1.264 . . . . 0.0 110.758 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.5 m -52.43 141.62 19.42 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.445 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.7 m -59.35 172.84 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 113.86 -1.518 . . . . 0.0 113.306 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.23 126.0 23.02 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.999 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.95 -24.35 32.31 Favored Glycine 0 N--CA 1.487 2.058 0 CA-C-N 114.981 -1.009 . . . . 0.0 111.583 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.7 mt -89.99 165.8 13.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 122.195 0.997 . . . . 0.0 112.073 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -140.99 142.37 34.29 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 46.7 t -76.95 105.06 7.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.996 1.435 . . . . 0.0 114.531 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -83.1 115.92 4.11 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.75 151.08 6.59 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 124.52 0.777 . . . . 0.0 111.832 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 165.15 -162.54 35.79 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 24' ' ' PRO . 16.4 t-20 -160.27 99.71 1.41 Allowed Pre-proline 0 N--CA 1.495 1.795 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 23' ' ' ASN . 14.6 Cg_endo -70.2 139.3 55.09 Favored 'Cis proline' 0 N--CA 1.489 1.212 0 O-C-N 122.617 0.799 . . . . 0.0 111.08 -3.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -54.63 163.49 0.92 Allowed 'General case' 0 N--CA 1.503 2.192 0 O-C-N 124.405 1.066 . . . . 0.0 110.708 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 mttp -155.05 127.22 7.72 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.224 0.535 . . . . 0.0 112.268 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 60.8 m -75.63 147.81 39.24 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 114.483 -1.235 . . . . 0.0 110.305 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.46 -167.49 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -108.96 146.0 16.58 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.808 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.74 -47.11 11.51 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 105.943 -1.873 . . . . 0.0 105.943 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 18.9 t-80 -95.69 52.8 1.38 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 104.78 -2.304 . . . . 0.0 104.78 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.71 56.02 0.61 Allowed 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 113.346 -1.752 . . . . 0.0 107.552 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 116.783 -1.579 . . . . 0.0 109.525 -179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . . . . . . . . . 6.3 p -60.21 -178.75 0.09 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.805 1.316 . . . . 0.0 111.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 m -102.06 147.22 26.85 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.512 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.42 174.08 24.58 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.04 103.15 0.43 Allowed 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 136.03 -11.67 4.17 Favored Glycine 0 N--CA 1.497 2.703 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.802 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 54.9 m -116.5 135.77 53.54 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.24 -170.35 1.16 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 123.623 0.577 . . . . 0.0 111.824 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 24.2 p -117.86 145.41 44.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 123.897 0.748 . . . . 0.0 112.602 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HYP . . . . . 0.661 ' HA ' ' C ' ' A' ' 11' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HYP . . . . . 0.661 ' C ' ' HA ' ' A' ' 10' ' ' HYP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -50.15 132.45 23.72 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.7 m -56.04 138.17 49.75 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.829 -1.148 . . . . 0.0 111.172 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -56.05 173.52 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.467 -1.697 . . . . 0.0 112.476 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 39.7 ttm -56.04 127.52 30.91 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.444 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.95 -24.88 29.81 Favored Glycine 0 N--CA 1.485 1.929 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.825 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.557 HD23 ' O ' ' A' ' 28' ' ' ILE . 0.4 OUTLIER -95.73 165.77 12.14 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.589 1.185 . . . . 0.0 113.767 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 28' ' ' ILE . 4.2 ptm180 -141.55 149.34 40.68 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 111.756 -2.475 . . . . 0.0 106.037 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.4 t -77.24 100.42 5.83 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -76.62 104.88 1.93 Allowed Glycine 0 N--CA 1.496 2.687 0 N-CA-C 105.484 -3.046 . . . . 0.0 105.484 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.38 95.48 1.35 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 25' ' ' GLN . . . -118.46 -150.29 8.86 Favored Glycine 0 N--CA 1.497 2.744 0 CA-C-N 113.548 -1.66 . . . . 0.0 108.991 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -160.47 97.07 1.44 Allowed Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.949 0.441 . . . . 0.0 110.757 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -64.2 141.55 44.74 Favored 'Cis proline' 0 N--CA 1.487 1.127 0 C-N-CA 125.085 -0.798 . . . . 0.0 110.666 -5.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HA ' ' H ' ' A' ' 22' ' ' GLY . 29.7 mt-30 -58.53 167.76 1.35 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.479 1.112 . . . . 0.0 110.606 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mttp -161.1 130.25 4.69 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 71.2 m -76.36 148.92 37.1 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 18' ' ' ARG . 0.1 OUTLIER -136.62 -174.67 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 179.786 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.46 144.36 17.26 Favored Glycine 0 N--CA 1.485 1.92 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.113 -179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.83 -48.33 16.74 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 106.292 -1.744 . . . . 0.0 106.292 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -95.84 50.28 1.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CGU . . . . . 0.456 ' CG ' ' H ' ' A' ' 33' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.456 ' H ' ' CG ' ' A' ' 32' ' ' CGU . 0.1 OUTLIER -126.89 32.99 5.01 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 112.671 -2.059 . . . . 0.0 106.081 179.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 116.384 -1.769 . . . . 0.0 111.319 -179.974 . . . . . . . . 0 0 . 1 stop_ save_